HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The transcription factor nuclear factor interleukin 6 mediates pro- and anti-inflammatory responses during LPS-induced systemic inflammation in mice.

Abstract
The transcription factor nuclear factor interleukin 6 (NF-IL6) plays a pivotal role in neuroinflammation and, as we previously suggested, hypothalamus-pituitary-adrenal-axis-activation. Here, we investigated its contribution to immune-to-brain communication and brain controlled sickness symptoms during lipopolysaccharide (LPS)-induced (50 or 2500 μg/kg i.p.) systemic inflammation in NF-IL6-deficient (KO) or wildtype mice (WT). In WT LPS induced a dose-dependent febrile response and reduction of locomotor activity. While KO developed a normal fever after low-dose LPS-injection the febrile response was almost abolished 3-7 h after a high LPS-dose. High-dose LPS-stimulation was accompanied by decreased (8 h) followed by enhanced (24 h) inflammation in KO compared to WT e.g. hypothalamic mRNA-expression including microsomal prostaglandin E synthase, inducible nitric oxide synthase and further inflammatory mediators, neutrophil recruitment to the brain as well as plasma levels of inflammatory markers such as IL-6 and IL-10. Interestingly, KO showed reduced locomotor activity even under basal conditions, but enhanced locomotor activity to novel environment stress. Hypothalamic-pituitary-adrenal-axis-activity of KO was intact, but tryptophan-metabolizing enzymes were shifted to enhanced serotonin production and reuptake. Overall, we showed for the first time that NF-IL6 plays a dual role for sickness response and immune-to-brain communication: acting pro-inflammatory at 8h but anti-inflammatory at 24 h after onset of the inflammatory response reflecting active natural programming of inflammation. Moreover, reduced locomotor activity observed in KO might be due to altered tryptophan metabolism and serotonin reuptake suggesting some role for NF-IL6 as therapeutic target for depressive disorders.
AuthorsJenny Schneiders, Franziska Fuchs, Jelena Damm, Christiane Herden, Rüdiger Gerstberger, Denis Melo Soares, Joachim Roth, Christoph Rummel
JournalBrain, behavior, and immunity (Brain Behav Immun) Vol. 48 Pg. 147-64 (Aug 2015) ISSN: 1090-2139 [Electronic] Netherlands
PMID25813145 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Lipopolysaccharides
  • CCAAT-Enhancer-Binding Protein-delta
Topics
  • Animals
  • Brain (drug effects, metabolism)
  • CCAAT-Enhancer-Binding Protein-delta (genetics, metabolism)
  • Dose-Response Relationship, Drug
  • Female
  • Hypothalamo-Hypophyseal System (metabolism)
  • Illness Behavior (drug effects)
  • Inflammation (chemically induced, metabolism)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Mice
  • Mice, Knockout
  • Motor Activity (drug effects)
  • Neutrophil Infiltration (drug effects)
  • Pituitary-Adrenal System (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: